Quorum X Diagnostics

Quorum X Diagnostics

Early Stage

Rapid at-home test for COVID antigen Test

Rapid at-home test for COVID antigen Test


Raised to Date: Raised: $0

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type




SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap




Rolling Commitments ($USD)

Not Funded
Reporting Date


Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise


Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



Tucker, Georgia

Business Type


Quorum X Diagnostics, with a valuation of $25 million, is raising funds on Wefunder. The company has developed a take-home lateral flow test to detect CoV-2 during the incubation period. The test will allow the detection of COVID even before the onset of symptoms. The company has already used the same technology to build QXD-1 Fast Test for Pseudomonal Pneumonia Prototype. Quorum X Diagnostics has tested over 350 patient samples and has an anticipated market demand of 60-90 million tests weekly. Maria Nagy and Dr. Angel A. Rivera founded Quorum X Diagnostics in 2017. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $387,278. The campaign proceeds will be used to complete the manufacturing of the first 20,000 COVIDNOW kits, develop the phone app, and implement AI technology upgrades.

Summary Profit and Loss Statement

Most Recent Year Prior Year












Net Income



Summary Balance Sheet

Most Recent Year Prior Year




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 02/14/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Quorum X Diagnostics 04/29/2022 Wefunder $25,000,000 $0 SAFE Not Funded RegCF
Quorum X Diagnostics 12/03/2020 Wefunder $2,750,000 $206,921 SAFE Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Quorum X Diagnostics on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $25,000,000

Follow company

Follow Quorum X Diagnostics on Wefunder 2022

Buy Quorum X Diagnostics's Deal Report

Warning: according to the close date for this deal, Quorum X Diagnostics may no longer be accepting investments.

Quorum X Diagnostics Deal Report

Get KingsCrowd’s comprehensive report on Quorum X Diagnostics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Quorum X Diagnostics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Quorum X Diagnostics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge